66 research outputs found
Antibiotic administration in the critically ill - in need of intensive care!
A better understanding of antibiotic dosing in the critically ill will go a long way to enhancing the longevity of what is becoming an increasingly scarce resource. There are no new antibiotic classes nearing clinical production. We believe that correct antibiotic dosing will limit the increasing burden of antimicrobial resistance, minimise therapeutic failures and, most importantly, improve patient outcomes.
Comparative MIC evaluation of a generic ceftriaxone by broth microdilution on clinically relevant isolates from an academic hospital complex in South Africa
We evaluated the in vitro microbiological efficacy of a generic ceftriaxone product against several clinically significant organisms collected from sterile sites. The minimum inhibitory concentration (MIC) of each was determined simultaneously with the reference and the generic ceftriaxone product. Comparative analysis of MICs between the two products for each isolate was performed using both categorical (interpretive) agreement and essential (actual MIC value) agreement. A total of 260 isolates were tested. Overall, there was categorical agreement of 98.9% and essential agreement of 95.8%. The categorical agreement for all isolates (96.7 - 100%) accorded with international standards, as no very major errors were seen and the major error rate was less than 3%. Of the 90 isolates of E. coli (40), Klebsiella spp. (40) and Salmonella spp. (10), 87.6% had an MIC less than or equal to 0.12 mg/l. The generic ceftriaxone product showed equivalent efficacy by MIC determination to the reference formulation. Ceftriaxone remains a viable and useful antimicrobial agent against a variety of clinically relevant organisms in our setting.S Afr Med J 2012;102:102-103
TOp TEn resistant Microorganisms at intensive care unit: a 2018 global expert survey (TOTEM study protocol)
Background: This global survey will provide global expert ranking of the most urgent multidrug bacteria present at the intensive care units (ICU) that have become a threat in daily clinical practice. We believe efforts on education, investigation, funding and development of new antimicrobials or new antimicrobial approach should be directed in near future. The 2018 study protocol is reported here in.
Methods: A global survey will be performed using an electronic platform (SurveyMonkey®). The survey will compile data on key aspects of the actual threat of antimicrobial-resistant bacteria globally in the ICU
Endogenous heparin levels in the controlled asthmatic patient
Background. Since heparin possesses anti-inflammatory properties, it is hypothesised that asthmatic patients have decreased levels of circulating heparin compared with healthy individuals.
Design. We compared endogenous heparin levels in controlled asthmatic patients (53 adults) from the Asthma Clinic at Johannesburg General Hospital with those of healthy controls (26 adults) from the general population. Heparin levels in the blood samples were tested using the Chromogenix Coatest Heparin kit.
Result. The blood of the patients contained significantly lower levels of endogenous heparin compared with that of the healthy individuals, indicating that the anti-inflammatory properties afforded by heparin are absent in these patients
A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide®) to the innovator brand in critically ill patients
INTRODUCTION : Clinicians’ skepticism, fueled by evidence of inferiority of some multisource
generic antimicrobial products, results in the underutilization of more cost-effective generics,
especially in critically ill patients. The aim of this observational study was to demonstrate
equivalence between the generic or comparator brand of meropenem (Mercide®) and the leading
innovator brand (Meronem®) by means of an ex vivo technique whereby antimicrobial activity
is used to estimate plasma concentration of the active moiety.
METHODS : Patients from different high care and intensive care units were recruited for observation
when prescribed either of the meropenem brands under investigation. Blood samples
were collected over 6 hours after a 30 minute infusion of the different brands. Meropenem
concentration curves were established against United States Pharmacopeia standard meropenem
(Sigma-Aldrich) by using standard laboratory techniques for culture of Klebsiella pneumoniae.
Patients’ plasma samples were tested ex vivo, using a disc diffusion assay, to confirm antimicrobial
activity and estimate plasma concentrations of the two brands.
RESULTS : Both brands of meropenem demonstrated similar curves in donor plasma when concentrations
in vials were confirmed. Patient-specific serum concentrations were determined from
zones of inhibition against a standard laboratory Klebsiella strain ex vivo, confirming at least
similar in vivo concentrations as the concentration curves (90% confidence interval) overlapped;
however, the upper limit of the area under the curve for the ratio comparator/innovator exceeded
the 1.25-point estimate, i.e., 4% higher for comparator meropenem.
CONCLUSION : This observational, in-practice study demonstrates similar ex vivo activity and in
vivo plasma concentration time curves for the products under observation. Assay sensitivity is
also confirmed. Current registration status of generic small molecules is in place. The products
are therefore clinically interchangeable based on registration status as well as bioassay results, demonstrating sufficient overlap for clinical comfort. The slightly higher observed comparator
meropenem concentration (4%) is still clinically acceptable due to the large therapeutic index
and should ally fears of inferiority.Ranbaxy (S.A)
(Pty) Ltdwww.dovepress.comam2016Pharmacolog
HIV Infection as Risk Factor for Death among Hospitalized Persons with Candidemia, South Africa, 2012-2017.
We determined the effect of HIV infection on deaths among persons >18 months of age with culture-confirmed candidemia at 29 sentinel hospitals in South Africa during 2012-2017. Of 1,040 case-patients with documented HIV status and in-hospital survival data, 426 (41%) were HIV-seropositive. The in-hospital case-fatality rate was 54% (228/426) for HIV-seropositive participants and 37% (230/614) for HIV-seronegative participants (crude odds ratio [OR] 1.92, 95% CI 1.50-2.47; p<0.001). After adjusting for relevant confounders (n = 907), mortality rates were 1.89 (95% CI 1.38-2.60) times higher among HIV-seropositive participants than HIV-seronegative participants (p<0.001). Compared with HIV-seronegative persons, the stratum-specific adjusted mortality OR was higher among HIV-seropositive persons not managed in intensive care units (ORÂ 2.27, 95% CI 1.47-3.52; p<0.001) than among persons who were (ORÂ 1.56, 95% CI 1.00-2.43; p = 0.05). Outcomes among HIV-seropositive persons with candidemia might be improved with intensive care
Patient and family engagement in the ICU: report from the task force of the world federation of societies of intensive and critical care medicine
Patient and family engagement plays an important role in the intensive care unit (ICU), however the degree to which practices are being implemented globally is not known.To provide insights, a task force of the World Federation of Societies of Intensive and Critical Care Medicine conducted a cross-sectional survey.A total of 345 responses were received from 40 countries. Varying practices with respect to patient and family engagement were reported. Majority of those responding to individual survey questions (n=109, 61.2%) provided written materials on the ICU to family members. Just over half (n=184, 53.8%) of respondents identified that structured patient and family care conferences were held to review goals of care. Practices such as open visitation were reported by 39.6% (n=136), and family presence during resuscitation were reported to be fully (12%, n=41) or somewhat adopted (33%, n=113) by less than half of respondents. ICU diaries, music or pet therapy, or the use of a patient and family advisory group were reported by less than half of respondents.We document and hence provide successful implementation techniques, tactics, and strategies that could help clinicians to address barriers to implementing patient and family engagement in the ICU
Core elements of general supportive care for patients with sepsis and septic shock in resource-limited settings
Federation of Infectious Diseases Societies of Southern Africa guideline : recommendations for the detection, management and prevention of healthcare-associated Candida auris colonisation and disease in South Africa
Candida auris has been detected at almost 100 South African hospitals, causing large
outbreaks in some facilities, and this pathogen now accounts for approximately 1 in 10 cases
of candidaemia. The objective of this guideline is to provide updated, evidence-informed
recommendations outlining a best-practice approach to prevent, diagnose and manage
C. auris disease in public- and private-sector healthcare settings in South Africa. The 18
practical recommendations cover five focus areas: laboratory identification and antifungal
susceptibility testing, surveillance and outbreak response, infection prevention and control,
clinical management and antifungal stewardship.The South African Society for Clinical Microbiology and the Federation of Infectious Diseases Societies of Southern Africa.https://sajid.co.za/index.php/sajidpm2020School of Health Systems and Public Health (SHSPH
- …